This summer, Takeda Pharmaceuticals Co. Ltd. stopped sales of Actos in both France and Germany. After that decision FDA issued warnings about the cancer risk based on new research, but they have allowed sales to continue.
Doctors are being told not to prescribe Actos for people who have or have had bladder cancer.
In the past week, the first of what lawyers predict will be thousands of lawsuits were filed in courts across the country. It is claimed that Actos triggered bladder cancer, in some cases fatal, in clients who took the pills
daily for years.